ALS MND Daily News Digest

Cytokinetics Announces CK-2017357 Receives Fast Track Designation From the FDA ... MarketWatch (press release) ... its fast skeletal muscle troponin activator, has received Fast Track designation from the US Food and Drug Administration (FDA) for the potential treatment of amyotrophic lateral sclerosis (ALS), also commonly known as Lou Gehrig's Disease. See all stories on this topic »